ES363068A1 - Un procedimiento para la preparacion de 11-beta-cloro-este-roides. - Google Patents

Un procedimiento para la preparacion de 11-beta-cloro-este-roides.

Info

Publication number
ES363068A1
ES363068A1 ES363068A ES363068A ES363068A1 ES 363068 A1 ES363068 A1 ES 363068A1 ES 363068 A ES363068 A ES 363068A ES 363068 A ES363068 A ES 363068A ES 363068 A1 ES363068 A1 ES 363068A1
Authority
ES
Spain
Prior art keywords
alpha
chloro
pyrazolino
activity
methylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES363068A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of ES363068A1 publication Critical patent/ES363068A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/0035Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a hydroxy group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0068Nitrogen and oxygen at position 16(17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES363068A 1968-01-29 1969-01-29 Un procedimiento para la preparacion de 11-beta-cloro-este-roides. Expired ES363068A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4570/68A GB1260465A (en) 1968-01-29 1968-01-29 11beta-CHLORO-19-NOR-STEROIDS

Publications (1)

Publication Number Publication Date
ES363068A1 true ES363068A1 (es) 1971-06-16

Family

ID=9779640

Family Applications (1)

Application Number Title Priority Date Filing Date
ES363068A Expired ES363068A1 (es) 1968-01-29 1969-01-29 Un procedimiento para la preparacion de 11-beta-cloro-este-roides.

Country Status (14)

Country Link
JP (2) JPS4828907B1 (da)
AT (1) AT309703B (da)
BE (1) BE727578A (da)
BR (1) BR6905985D0 (da)
CH (2) CH592688A5 (da)
DE (1) DE1904325C3 (da)
DK (1) DK128715B (da)
ES (1) ES363068A1 (da)
FR (1) FR2000924A1 (da)
GB (1) GB1260465A (da)
IE (1) IE33924B1 (da)
IL (1) IL31515A0 (da)
NL (1) NL6901342A (da)
SE (2) SE364267B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52119945U (da) * 1976-03-08 1977-09-12
US5710293A (en) * 1995-10-13 1998-01-20 The Population Council, Center For Biomedical Research Method of preparation of ester derivatives of steroids

Also Published As

Publication number Publication date
IL31515A0 (en) 1969-03-27
IE33924B1 (en) 1974-12-11
JPS4828907B1 (da) 1973-09-05
JPS4830051B1 (da) 1973-09-17
BE727578A (da) 1969-07-29
FR2000924A1 (da) 1969-09-19
AT309703B (de) 1973-08-27
CH592688A5 (da) 1977-11-15
DK128715B (da) 1974-06-24
SE364267B (da) 1974-02-18
IE33924L (en) 1969-07-29
BR6905985D0 (pt) 1973-04-19
SE386903B (sv) 1976-08-23
GB1260465A (en) 1972-01-19
CH578017A5 (da) 1976-07-30
NL6901342A (da) 1969-07-31
DE1904325C3 (de) 1978-10-26
DE1904325A1 (de) 1969-09-04
DE1904325B2 (de) 1978-02-16

Similar Documents

Publication Publication Date Title
MY103518A (en) Steroid 5- -reductase inhibitors
IL40376A0 (en) Pharmaceutical compositions containing an estrogenic and a progestational substance
ES363068A1 (es) Un procedimiento para la preparacion de 11-beta-cloro-este-roides.
IL49132A0 (en) New steroids of the androstane series,their preparation and pharmaceutical compositions containing them
PH12178A (en) 11-substituted steroids of the estrane series and pharmaceutical composition thereof
GB1488995A (en) Compositions containing anti-androgenic compounds
CA970281A (en) Anesthetic composition containing an anesthetic steroid
Swyer Progestogens and their clinical uses: Part I
IL36654A (en) 3-cyclopentyl ethers of 7alpha-methyl-3,16alpha,17(alpha and beta)-trihydroxy-delta 1,3,5(10)-estratriene,their manufacture and estrogenic pharmaceutical compositions containing them
GB1116795A (en) An oral contraceptive preparation
IL36653A0 (en) A new highly active oestrogenic steroid of the estrane series,its manufacture and pharmaceutical compositions containing it
ES338729A1 (es) Procedimiento de preparacion de 15, 16beta-metilenesteroi- des de la serie 19-nor-androstan.
FR2097045A1 (en) 17-ethynylgon-4-en-3-ones - with progestomimetic activity useful as contraceptives and for gynaecological disorders
IL47859A0 (en) A novel steroidal glycoside,its preparation and pharmaceutical compositions containing it
IL36652A0 (en) A new oestrogenically highly active steroid of the estrane series,its manufacture and pharmaceutical compositions containing it
IL36214A (en) 13beta-ethyl-17alpha-methyl-18,19-dinorpregna-4,9-diene-3,20-dione,process of preparation and pharmaceutical compositions containing it
GB1313659A (en) 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds
GB1260463A (en) 11beta-BROMO-19-NOR-STEROIDS
GR22822B (el) Μεθοδος δια την παρασκευην νεων στερινων.
AU247661B2 (en) Steroid compounds for use in the synthesis of 9 a-fluoro-1 b, 17 a, 21-trihydroxy-16 a-methyl-pregna-1, 4-dien-3, 20-dione, processes for preparation thereof and for their conversion
ES395365A1 (es) Procedimiento para la obtencion de agentes anticonceptivos.
GB1164808A (en) Novel Hydrogen-Bonded Compounds and Pharmaceutical Compositions prepared therefrom
CA880871A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 6-METHYL-16-METHYLENE-17.alpha.-HYDROXY-4,6-PREGNADIENE-3,20-DIONE 17-ACETATE
AU5631060A (en) Steroid compounds for use in the synthesis of 9 a-fluoro-1 b, 17 a, 21-trihydroxy-16 a-methyl-pregna-1, 4-dien-3, 20-dione, processes for preparation thereof and for their conversion
AU254805B2 (en) 3, 20-diketals of 17- hydroxy-16 -methyl-pregn 5-ene-3, 20-dione, their preparation and conversion to other steriods